From: The EU-AIMS Longitudinal European Autism Project (LEAP): clinical characterisation
Total | Adults | Adolescents | Children | Mild ID | ||||||
---|---|---|---|---|---|---|---|---|---|---|
ASD | TD/ID | ASD | TD | ASD | TD | ASD | TD | ASD | ID | |
Autism symptomatology measures | ||||||||||
SRS-2 | 72.12a (11.75) n = 357 | 47.96a (9.64) n = 158 | 64.39a (10.85) n = 99 | 47.59b (5.89) n = 90 | 74.31a (10.71) n = 105 | 45.71a (6.38) n = 75 | 75.04a (11.25) n = 90 | 44.86a (5.28) n = 57 | 76.41a (9.93) n = 63 | 64.55a (10.29) n = 20 |
CSBQ/ASBQ | 46.88a (16.59) n = 225 | 7.10a (9.94) n = 139 | 32.05b (14.88) n = 102 | 7.85b (8.65) n = 82 | 44.95a (16.87) n = 105 | 5.88a (8.71) n = 75 | 45.93a (16.37) n = 87 | 5.21a (7.91) n = 53 | 55.55a (13.74) n = 33 | 24.55a (10.61) n = 11 |
AQ | – | – | 82.53 be (19.49) n = 105 | 47.26be (14.92) n = 82 | 94.66ad (17.92) n = 99 | 42.63ad (16.49) n = 70 | 92.74ac (17.18) n = 86 | 39.46ac (17.15) n = 54 | 99.36ad (17.33) n = 28 | 81.30ad (12.02) n = 10 |
RBS-R | 16.75a (13.85) n = 346 | 2.52a (8.04) n = 157 | 10.73a (10.13) n = 91 | – | 16.53a (13.95) n = 106 | 1.01a (2.09) n = 73 | 19.21a (12.94) n = 87 | 1.07a (2.17) n = 56 | 22.55a (16.82) n = 62 | 11.86a (18.62) n = 22 |
SSP | 138.13a (27.46) n = 293 | 175.39a (17.12) n = 141 | 155.62a (23.88) n = 60 | – | 137.35a (26.85) n = 96 | 180.52a(11.00) n = 62 | 130.31a (24.77) n = 85 | 175.68a (12.75) n = 56 | 132.17a (28.37) n = 52 | 155.11a (28.43) n = 19 |